|
UBE2A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.424500E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.74429999999904E-05 |
| Normal-vs-Stage2 |
4.269900E-02 |
| Normal-vs-Stage3 |
1.304600E-03 |
| Normal-vs-Stage4 |
1.014550E-01 |
| Stage1-vs-Stage2 |
4.957400E-01 |
| Stage1-vs-Stage3 |
6.149200E-01 |
| Stage1-vs-Stage4 |
3.930400E-01 |
| Stage2-vs-Stage3 |
3.736000E-01 |
| Stage2-vs-Stage4 |
8.408600E-01 |
| Stage3-vs-Stage4 |
2.906400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.904690E-03 |
| Normal-vs-AfricanAmerican |
2.47099999999278E-05 |
| Normal-vs-Asian |
1.736400E-01 |
| Caucasian-vs-AfricanAmerican |
3.950300E-02 |
| Caucasian-vs-Asian |
8.586600E-01 |
| AfricanAmerican-vs-Asian |
5.707200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.043700E-03 |
| Normal-vs-Female |
1.520910E-03 |
| Male-vs-Female |
3.670400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.803500E-03 |
| Normal-vs-Age(41-60Yrs) |
6.061900E-03 |
| Normal-vs-Age(61-80Yrs) |
5.770600E-04 |
| Normal-vs-Age(81-100Yrs) |
3.735800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.062000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.280800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.304600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.973400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.131400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.916000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.312000E-01 |
| Normal-vs-Grade 2 |
1.482270E-02 |
| Normal-vs-Grade 3 |
3.63299999994737E-06 |
| Normal-vs-Grade 4 |
1.048760E-01 |
| Grade 1-vs-Grade 2 |
9.263600E-01 |
| Grade 1-vs-Grade 3 |
1.831040E-01 |
| Grade 1-vs-Grade 4 |
9.879800E-01 |
| Grade 2-vs-Grade 3 |
8.116200E-03 |
| Grade 2-vs-Grade 4 |
8.976200E-01 |
| Grade 3-vs-Grade 4 |
1.462650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.391400E-04 |
| Normal-vs-ccB subtype |
5.020400E-03 |
| ccA subtype-vs-ccB subtype |
7.732000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.376700E-03 |
| Normal-vs-N1 |
2.710800E-01 |
| N0-vs-N1 |
8.070400E-01 |
|
|
